
Why am I not losing weight on tirzepatide? The common reasons, from dose timing to protein and sleep, what trials show is normal, and when to check in.
Weight loss stories online tend to skip straight from "week one" to the dramatic after photo. Real life on tirzepatide usually has a much messier middle, full of slow weeks, stubborn scales, and the occasional "is this even working?"
If you're not losing weight on tirzepatide, the most common reasons are timing (the early weeks are mostly about getting used to the medication), where you are in your dose schedule, and everyday factors like protein, sleep, and liquid calories. A smaller group of people simply respond less, and that's worth a conversation with your provider, not a reason for self-blame.
If you're with HealthiCare, your care team can look at your progress with you and talk through whether anything in your tirzepatide plan should change.

It can be a little longer than most of us hope. According to the Zepbound prescribing information, treatment starts at 2.5 mg a week for four weeks, and that starting dose is meant to help your body adjust, not to be a weight-loss dose on its own. From there, the dose is typically increased in steps of 2.5 mg, at least four weeks apart, by your prescriber.
That means the first month or two can feel underwhelming, especially if you were expecting the kind of results you've seen on social media. Appetite often changes before the scale does. We go deeper on the timeline in how long tirzepatide takes to work, but the short version is that patience in the early weeks is part of the process, not a sign it's failing.
In the SURMOUNT-1 trial of 2,539 adults with obesity or overweight, people on tirzepatide lost an average of 15% to 21% of their body weight over 72 weeks, depending on dose, compared with about 3% on placebo. That's a big effect, but notice the timeframe: 72 weeks is nearly a year and a half.

The same trial also shows that not everyone responds the same way. Between 85% and 91% of people on tirzepatide lost at least 5% of their body weight, which means roughly one in ten didn't reach that mark. These are trial averages for brand-name tirzepatide (Zepbound), and individual results vary. Compounded tirzepatide is not FDA-approved and wasn't studied in these trials, so these numbers can't be applied to it directly.
If you're on semaglutide instead, the pattern is similar. In the STEP 1 trial, people lost an average of about 15% over 68 weeks, with a wide range from person to person.
This one is so frustrating, and so common. A few things can be going on at once.
The scale is noisy. Water shifts from salt, hormones, hard workouts, or constipation (a familiar GLP-1 companion) can hide real progress for a week or more. Weekly averages tend to tell a truer story than any single morning.
"Barely eating" can hide calories in drinks. Lattes, smoothies, juice, and alcohol slide right past a quieter appetite because they don't feel like food. Ever looked back at a day and realized half of what you had came through a straw? It happens to a lot of people.
Too little protein can backfire. When appetite is low, protein is often the first thing to go, and that can mean losing more muscle and feeling more tired. Our guide to getting enough protein on a GLP-1 has some easy ideas.
Sleep and stress matter more than they get credit for. Short sleep can turn up hunger and cravings, even on a GLP-1. Healthi has a great look at why you're hungrier when you're tired.

Sometimes, yes. A large 2026 study in Nature of nearly 28,000 people taking GLP-1 medicines found that genetics, along with age, sex, treatment length, and which drug people took, helped explain why some people lose more than others. Even so, all of those factors together explained only about a quarter of the differences, so there's still a lot no one can predict ahead of time.
Other health factors can play a role too. The NIH notes that some medicines, such as certain steroids, antidepressants, and seizure medicines, and some conditions, such as an underactive thyroid, can make weight harder to lose. Please don't stop any of your medications on your own. Instead, it's worth bringing a list of everything you take to your next check-in.
If you lost weight steadily and then stalled, that's a plateau, and it's a normal part of the process. Your body gets smaller, it needs less energy, and the pace naturally slows. We've written a whole guide to why GLP-1 plateaus happen and what helps.
Not losing much from the start is a little different. It's often about timing or dose, and sometimes about how your body responds. Either way, it's information, not a judgment. Reflecting on what's changed (your dose, your routine, your sleep, your stress) can help you and your provider figure out which one you're dealing with.
There's no secret trick here, just a few things that make a real difference for many people. Some find that putting protein first at meals and keeping a simple food log for a week or two makes patterns jump out. Others notice the biggest shift from adding a couple of short strength sessions, since strength training helps protect muscle on a GLP-1. And many people feel better simply judging progress by the month instead of the day.
Pick whichever of these sounds most doable for you right now. One small change you'll actually keep usually beats five you'll abandon by Friday.
Reach out if you've been on a steady dose for a few months with little change, if you're eating very little and feeling weak or dizzy, or if you're unsure where you are in your dose schedule. Only your prescriber should decide whether and when to change your dose, so please don't adjust it yourself or take extra. And seek care right away for severe stomach pain that won't go away, ongoing vomiting, or signs of dehydration.
Slow progress on tirzepatide is common, and it's rarely the whole story. Timing, dose, the scale's mood swings, and everyday habits all play a part, and a smaller group of people simply respond less. None of it means you've done something wrong.
If you'd like a hand figuring out what's going on, HealthiCare's care team is happy to look at the full picture with you. And if you're thinking about starting or switching to a GLP-1 program, you can start an online visit whenever you're ready. The scale will catch up. Give it a little time.
This article is for general information and isn't a substitute for medical advice. Never start, stop, or change a medication dose without talking to your prescriber, and seek medical care right away for the warning signs above.
Treatment starts at 2.5 mg a week for four weeks to help your body adjust, and doses increase gradually after that. Many people notice appetite changes first, and the scale often takes longer to follow.
Water shifts, constipation, hormones, and calories from drinks can all hide progress for a while. Too little protein and short sleep can also make things harder. Weekly averages usually tell a truer story than a single weigh-in.
Yes. In the SURMOUNT-1 trial, average weight loss built up over 72 weeks, and about 1 in 10 people didn't reach 5% weight loss. These are trial averages for brand-name tirzepatide, and individual results vary.
Only your prescriber should decide whether to change your dose. Please don't adjust it yourself or take extra. Share your progress, eating, and any side effects so your provider can review your plan with you.
Many of the same reasons apply, including timing, dose schedule, protein, sleep, and liquid calories. Some medicines and health conditions can also make weight loss harder, so it's worth reviewing everything with your provider.
Reach out if you've been on a steady dose for a few months with little change, or if you're eating very little and feel weak or dizzy. Get care right away for severe stomach pain, ongoing vomiting, or signs of dehydration.
November 19, 2026